LFTD PARTNERS INC.

LIFD ·Healthcare, Drug Manufacturers - General, United States

Net Cash Flow Breakdown

FY2025 FY2023 FY2022 FY2021

Total Cash from Operations: $1.3M

Line Item	Value	% of Total
Capital Expenditures	$59.5K	4.5%
Other Financing	$1.3M	95.5%